Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion

Submitted by admin on January 13, 2025 - 5:43pm

Source:

CNBC

News Tags:

Headline:

snippet:

Moderna lowered its 2025 sales guidance by roughly $1 billion, as it continues to cut costs.
The biotech company now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half of the year.
The announcement comes as Moderna charts a path forward after the rapid decline in demand for its Covid vaccine.

Search form